Lmna-related dilated cardiomyopathy

Clinical trials for Lmna-related dilated cardiomyopathy explained in plain language.

Never miss a new study

Get alerted when new Lmna-related dilated cardiomyopathy trials appear

Sign up with your email to follow new studies for Lmna-related dilated cardiomyopathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Gene therapy trial aims to fix heart muscle in rare genetic disease

Disease control Recruiting now

This early-stage trial tests a single dose of a gene therapy called NVC-001 in 21 adults with a genetic form of dilated cardiomyopathy (LMNA mutation). The therapy uses a harmless virus to deliver a modified gene into heart cells, aiming to protect the heart muscle. The main goal…

Matched conditions: LMNA-RELATED DILATED CARDIOMYOPATHY

Phase 1/2 • Sponsor: Nuevocor Pte. Ltd. • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

Lmna-related dilated cardiomyopathy

Get alerted when new Lmna-related dilated cardiomyopathy trials appear

Gene therapy trial aims to fix heart muscle in rare genetic disease